Pim French

Assoc Prof

Erasmus MC

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Medical Imaging Medical Imaging professors in Netherlands

Contact this professor

ORCID

Google Scholar

About

Dr. Pim French is an Associate Professor at Erasmus MC in the Netherlands. His research focuses on gliomas, specifically IDH-mutant astrocytomas, and includes studies on tumor biology, molecular testing, and treatment outcomes. Recent publications highlight topics such as tumor grading, epigenetic changes, and the prognostic implications of various factors in glioma progression.

Pim French

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip

Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread

Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection - Update 1

Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study

Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma

Evaluating the predictive value of glioma growth models for low-grade glioma after tumor resection

IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection

Mitotic count is prognostic in IDH-mutant astrocytoma without homozygous deletion of CDKN2A/B.

Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids

Primary brain tumours in adults

Transcriptome analysis reveals tumor microenvironment changes in glioblastoma

Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing

Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?

Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

Collaborators (26)

Luciano Garofano

Johan Koekkoek

Martin van den Bent

Pieter Wesseling

Maarten Wijnenga

Linda Dirven

Sebastian van der Voort

Monika Hegi

Stefan Klein

John Joo Yiul Lee

Martin van Royen

Fulvio D'Angelo

Bastiaan Tops

Gianluca Marucci

Benjamin M Ellingson

Wytske M. van Weerden

Frederick Varn

Franck Bielle

Daniel J. Brat

Bjarne Winther Kristensen

Felix Sahm

Luca Bertero

Johan Pallud

erik danen

Lucy Stead

Antony Michealraj Kulandai Manuvel

How do I reach out?

Meet Kite AI